The limited number and capacities of notified bodies currently designated under Regulation (EU) 2017/746 has created bottlenecks for the certification of in vitro diagnostic medical devices during the transitional periods provided for in Article 110(3) of that Regulation.
Recital 3, Regulation (EU) 2023/503
In forcesince 1 Dec 2022